Friday, 8 December 2017

Enteric Disease Testing to Alleviate Mortality among Humans

Increasing presence of pathogens in the air and rising number of casualties have increased the requirement of timely enteric disease testing in humans. Enteric diseases, resulting in symptoms such as nausea, diarrhea, and vomiting, generally happen due to consumption of contaminated food or water. Such diseases are highly communicable and timely testing can help doctors diagnose the accurate problem and provide early treatment. 


Rising Strategic Initiatives from Healthcare Organizations

Generally, there are three different types of enteric diseases: bacterial, viral, and parasitic. In 2016, enteric diseases caused by bacteria dominated the market. Salmonella, C. difficile, Shigella, E. coli, and Campylobacter are few bacteria that can cause enteric diseases. Increasing dependency on fast food and insufficient health awareness among humans is giving rise to bacterial infections. According to World Health Organization (WHO), around 1,72,454 people across the world get infected by cholera, resulting in high mortality rate. To handle the situation, various institutes and organizations in healthcare are taking strategic initiatives by promoting timely testing for such infections through healthcare camps and improving vaccines. For instance, a team of researchers at the University of Buffalo in New York is developing a new vaccine that will eradicate maximum bacteria strains causing pneumonia. Current versions of the vaccine can eradicate only 23 forms of Streptococcus pneumonia, including sepsis and meningitis. This advanced vaccine, on the other hand, can handle 72 forms of bacteria out of 90. 

Market Insights

Growing number of molecular diagnostic centers and advanced diagnostic technologies are expected to boost the global enteric disease testing market. In addition, rising dependency of humans on unhygienic fast food and increasing cases of mortality due to enteric infections can augment market growth. Frequent strategic initiatives taken by various healthcare organizations are likely to help the market reach a value of USD 4.2 billion by 2025, states Grand View Research Inc. in a recent report.

Some of the prominent players in the market are Alere Inc.; Quest Diagnostics; Bio Rad Laboratories; Becton Dickinson and Company; and Cepheid.

To get free sample request at:
https://www.grandviewresearch.com/industry-analysis/enteric-disease-testing-market/request

Wednesday, 6 December 2017

Imaging Chemicals Prove Beneficial for Medical and Mining Sectors

Growing prevalence of major health issues and rapid acceptance of advanced technologies is gradually increasing the demand for imaging chemicals. In addition, increasing use of organic pigments by companies manufacturing such imaging chemicals is boosting its demand. Using these high-performance chemicals in the imaging process can enhance image clarity. Hence, they are majorly being used in the medical industry for detection and diagnosis of various health issues. Imaging chemicals are also in demand in the mining industry owing to their gradual adoption in various mineral exploration activities. Most mining exploration projects follow satellite and aerial imaging to obtain accurate location of railway tracks, roads, and inhabited areas. 


Varied Uses of Imaging Agents and Developers

Major product-variants of imaging chemicals are imaging agents and developers. Both are attracting considerable demand from various industries. However, imaging agents have been dominating the overall market. Continuous product developments, high R&D investments, and increasing demand in the medical industry can further propel the demand for imaging agents. These agents are capable of producing high-quality images, which helps medical centers diagnose diseases more efficiently. For instance, Bracco Imaging S.p.A. recently acquired SurgVision, for developing a real-time Fluorescence Image Guided Surgery platform. The platform corresponds to an innovative intra-operative optical technique, which uses an infrared camera and contrast agent approach. The technique is designed to aid surgeons in distinguishing tumors from healthy tissue.

Developers are generally used for image optimization in industries. Black and white developers such as methyl phenidone, hydroxymethyl-methyl-phenidone, and dimezone are used to attain maximum image clarity. Considering the increasing demand for developers from medical and other industries, manufacturing companies are continuously working on the development of organic color developers. Such eco-friendly developments in imaging chemicals can augment its demand among versatile industries. 

Market Insights

Increasing demand for improved imaging in medical centers for diagnosing diseases can drive the growth of the global imaging chemicals market. Accurate diagnoses through improved images can avoid costly treatments, which is likely to benefit patients. Vouching these benefits of imaging chemicals, manufacturing companies are focused on product development through organic compounds. Frequent product launches, agreements, and mergers are key strategies of these companies to gain a competitive advantage in the market. This constant research input from manufacturers will also widen the scope of this market in the forecast period (2017-2025), states Grand View Research, Inc. in a recent report. The market is expected to value USD 11.9 billion by 2025. 

Some of the prominent players in the market are Kao Corporation, Vivimed Labs Ltd., BASF, Dow Chemical Company, Clariant Chemical Company, and Becton Dickinson and Company.

To get free sample request at:

Monday, 4 December 2017

New Systems Enable Innovation in Clinical Trial Supplies and Design

A clinical trial supply chain is more than just logistics. As many biopharmaceutical firms are expanding their operations across the globe, various elements of the trial may experience differences based on local regulations and infrastructure. Planning and management of clinical trial supplies is a complex task. Various factors such as regulatory compliance, temperature sensitivity, and drug safety and security have a considerable impact on costs and timelines of a study. Due to this, sponsors and clinical research organizations (CROs) have started focusing on clinical trial supply management.


Agile IRT/RTSM System for Supply Managers

By way of products and services, the market comprises manufacturing, supply chain management, and storage and distribution. Supply chain management is considered to be the leading segment thanks to advancement in technology and need to control R&D costs.

In the latest Xtalks webinar, industry experts discussed the importance of Agile Interactive Response Technology/Randomization and Trial Supply Management (Agile IRT/RTSM) in clinical trials. These systems allow developments in clinical trial designs and supply chain management. As procedures become more intricate and trials become patient-centric, the implemented system for randomization and clinical trial supply is going to be extremely essential for a better clinical systems strategy. These systems offer flexibility and speed, which can support complex procedures that need quick changes.

Market Insights

According to findings of a research report by Grand View Research, Inc., the global clinical trial supplies market is expected to witness expansion at a strong CAGR of 7% during the forecast period (from 2017 to 2025). Rising number of clinical trials, along with increasing complexity in conducting these trials, is a major growth driver for the global market. In addition, rising number of biosimilar and biologics drugs in clinical trials is estimated to contribute toward global market expansion.

Some of the leading companies operating in the worldwide market for clinical trial supplies are Thermo Fischer Scientific; PAREXEL International Corp.; Biocair International Ltd.; Almac Group Ltd.; Catalent Pharma Solutions; and Sharp Packaging Services.

To get free sample report at:
http://www.grandviewresearch.com/industry-analysis/clinical-trial-supplies-market/request

Friday, 1 December 2017

New Anti-aging Therapy using Astaxanthin Promises Better Results

Astaxanthin is reddish, naturally occurring, and powerful carotenoid pigment found in particular marine plants as well as animals. Astaxanthin is present in its maximum natural concentration in wild Pacific sockeye salmon. It is also present in algae, krill, shrimp, red trout, lobsters, and crab. It is one of the best natural antioxidants. It helps fight various health problems such as fatigue, joint pain, vision issues, and skin-related issues. 


Other key functions include:

Protecting the nervous system and cells from oxidative damage

Supporting cardiovascular health

Supporting immune system

Supporting brain health

Breakthrough Anti-aging Therapy using Astaxanthin

Owing to its many benefits, astaxanthin finds application in aquaculture and animal feed, cosmetics, nutraceuticals, and others. Rising demand for anti-aging creams and products is likely to benefit the cosmetics industry as a key application segment.

The John A. Burns School of Medicine of the University of Hawaii and Cardax Inc., Honolulu-based life sciences company, recently announced the results of their study assessing the use of astaxanthin in anti-aging therapy. The astaxanthin compound CDX-085 by Cardax showed capacity to considerably enhance the expression of the gene FOX03, which has an important role in longevity.

Market Overview

According to findings of a report by Grand View Research, Inc., the worldwide astaxanthin market is estimated to showcase rapid growth during the forecast period (from 2017 to 2025), reaching a value of USD 2.57 billion by 2025. Increased awareness about various health benefits and potential uses of astaxanthin is expected to help market expansion.

In addition, due to growing geriatric population, demand for cosmetics such as antioxidant products and anti-aging creams to enhance aesthetic appeal have increased. This factor is anticipated to boost the growth of the market over the next few years.

JX Nippon Oil and Energy Corp; Heliae Development, LLC; BlueOcean NutraSciences, Inc.; Fuji Chemical Industry Co., Ltd.; EID-Parry (India) Ltd.; and Cyanotech Corp. are some of the prominent companies operating in the worldwide astaxanthin market. These major companies are implementing strategies such as using new production technologies to gain the top market position.

To get free sample report at:

Thursday, 30 November 2017

Wind Turbine Operations and Maintenance to Become Safer with Introduction of Robotics

Components such as control systems, gears, electric systems, blades, rotors, generators, hydraulics, and sensors are integral parts of wind turbines and are susceptible to failure. Unexpected breakdown of turbine parts adversely affects productivity. Effective maintenance at regular periods of time helps curb failure rate and thus, enhance operational efficiency by reducing downtime.


What comprises ‘wind turbine operations and maintenance’?

Wind turbine operations and maintenance services include operation, troubleshoot, maintenance, and repair of wind turbines installed at wind farms. These services also consist of unscheduled maintenance, scheduled maintenance, remote monitoring, and asset administration. Generally, wind turbine manufacturers (mostly OEMs), independent service providers (ISPs), and in-house teams are involved in providing operations and maintenance services.

3M Partners with Santa Cruz to Use Drones for Wind Turbine Maintenance

Operations and maintenance of wind turbines involve high cost and risk. To address these issues, importance is being given to development of technologies that make wind turbine operations and maintenance safer and less costly. For instance, in August 2017, 3M teamed up with Santa Cruz to introduce small industrial robots mounted on drones that conduct routine inspections and maintenance of wind turbines. For the working, pilots with FAA-certificates will ensure safe flight perimeter and properly position the blades. After this, several specialized robots will conduct operations and maintenance with products by 3M.

Market Insights

Market growth can be largely attributed to widening capacity installations of wind energy. Increasing efforts to reduce dependence on fossil fuels are boosting adoption of renewable and clean energy sources such as wind energy. Conducive government policies and attractive incentives are encouraging development of wind farms across the globe, which in turn is likely to work in favor of the market. 

According to Grand View Research Inc., technological innovations and growing focus on establishing cost-effective operations and maintenance are estimated to propel the market over the coming years. On the flip side, sluggish growth in electric consumption worldwide can inhibit the growth of the market. 

Some of the key players in the market are GE Wind Turbine, Suzlon Group, Siemens Wind Power GmbH, Enercon GmbH, and Gamesa Corporation.

To get free sample report at: 

Vitamin D Testing for Preventing Chronic Illness

Vitamin D is a fat-soluble vitamin, principally obtained from sun exposure. It is available naturally in some food and it can be consumed in the form of dietary supplements.

Vitamin D comes in two forms, namely, ergocalciferol (vitamin D2), which is present in some fish and plants and cholecalciferol (vitamin D3), which is obtained from the sun. It is the predominant source of vitamin D for humans. 


Significance of Vitamin D

This vitamin helps intestinal absorption of calcium, phosphate, zinc, magnesium, and many other nutrients. It is essential for overall health improvement and especially for the growth of strong and healthy bones. Vitamin D as also reduces inflammation and improves the neuromuscular and immune function.

Deficiency of vitamin D makes the bones thin and fragile. It can also case rickets in kids and osteomalacia in adults. Children below the age five, pregnant and breast-feeding women, people with very little exposure to sunlight, and persons with darker skin tones can be at a higher risk of vitamin D deficiency.

Advanced Flash Chemiluminescence (CLIA) Technology

Two types of tests are used to inspect the level of Vitamin D in the body, namely, 25-Hydroxy Vitamin D abbreviated as 25 (OH) D and 1, 25-Dihydroxy Vitamin D. 

DiaSorin, an Italian multinational biotechnology company has developed ‘‘LIAISON’’ analyzer. The system uses chemiluminescent immunoassay (CLIA) technology to perform quantifiable determination of 25 (OH) D in human serum. The result of the test must be used in the combination with other clinical or laboratory examination.

The company’s another product; ‘LIAISON XL’ is a fully automated chemiluminescence analyser. It functions based on a “Flash” chemiluminescence (CLIA) technology with paramagnetic microparticle solid phase. It can perform complete sample processing along with measurement and evaluation of vitamin D levels.

Market Overview

According to Grand View Research, Inc.; the global vitamin D testing market is set to achieve nearly USD 1.1 billion by 2025. Increasing geriatric population and prevalence of celiac disease is projected to drive the market during the forecast period (2014 to 2025).

The 25 (OH) D test sector is anticipated to continue dominating the overall market during the forecast period. In 2016, North America led the market due to the presence of developed health care infrastructure and high awareness regarding routine screening and availability of the advanced products. Asia Pacific may emerge as the fastest growing region in the near future owing to improved healthcare infrastructure and expenditure in India, China, and Japan.

To get free sample report at:

OTT Devices and Services: Creating A More Personalized Viewing Experience

Over the top (OTT) devices and services have changed the way we consume content. So much so, that OTT streaming devices are now known to be the fourth most common in-home access point to the Internet, after desktops, smartphones, and tablets.

Major media brands now have the benefit of using OTT services to target viewers at a person-level, going beyond household-level. Platforms such as Amazon Fire, Amazon Alexa/Echo, Apple TV, and Roku are some of the most not able examples of OTT delivery systems that offer consumers a widening range of channels.

The Basics of OTT

OTT is a media distribution service that delivers TV and film content such as audio/video, text, VoIP (Voice over Internet Protocol), and other media via the Internet without user subscription to satellite pay-TV or cable service.The reason why OTT services are so compelling is that they offer cheap, flexible, and one of the best viewing experiences in the field.

Major business models of OTT services are Subscription Video on Demand (SVOD), Advertising VOD (AVOD), and Transactional VOD (TVOD). 

- SVOD

It is a type of service wherein the user can gain access to services through monthly/yearly subscriptions. The major benefit of these services is that the user can subscribe as well as unsubscribe at any point of time. The best example of SVOD services would be Netflix.

- AVOD

AVOD is a free yet least explored OTT service. In this, the user can gain access in exchange for watching all the displayed ads, instead of paying money. An example of AVOD can be YouTube.

- TVOD

TVOD services generally do not charge anything for creating a user profile or for signing up; instead, users will only pay based on the content they watch. These services offer attractive packages on select content to retain customers. They have been in the industry for a long time, but only through set top boxes (STBs) and not as a complete OTT service.

Demand for Best-quality Picture

Right from the start, the demand for OTT devices and services has grown much faster than expected, thanks to the increased availability of 4k (Ultra HD) movies and TV programs. To cater to the demand for better and higher-quality videos and pictures, the adoption of 4k set-top boxes was once the rage. However, users in this digital era expect quick access to these videos in TV-like visuals on devices of their choice, mostly smartphones, tablets, or other connected devices. Thus, companies in this industry are constantly innovating new technologies to meet changing consumer needs.

What’s New in OTT Devices and Services?

- comScore OTT Intelligence: A Breakthrough Service Measuring OTT Viewing on TVs

comScore, Inc. recently presented comScore OTT Intelligence, a syndicated service to measure OTT content viewing on TVsin the U.S. household. This service is based on their ground breaking research platform called Total Home Panel, which measures user behavior across home network-connected devices.

- Sports Illustrated (SI) Network by Time, Inc.

Another innovation in the field is the newly launched SVOD by Time, Inc. called SI Network. This new network will offera mix of documentaries, talk shows, and narrative programs under the tagline “Because you love sports. ”It will offer 130 hours of on-demand viewing and will also include original documentaries and insights from key SI reporters who cover a wide array of sports, the company said.

Increasing Affordability of OTT Devices and Services

A recent study by Grand View Research, Inc. finds that the value of the global OTT devices and services market may cross USD 165 billion by 2025. Growing popularity of OTT content due to increased affordability and trend of offering personalized user experience are key factors driving its adoption. Growing user reliance on mobile devices like smartphones and tablets and rapidly evolving consumer electronics like smart TVs will also have a major impact on the up take of OTT devices and services


According to industry experts, OTT will be a lot like conventional TV; only related components such as user experience/interface and content discovery will keep evolving. The industry still has a lot to look forward to over the coming years as TV consumption keeps on changing. Advertisers or media companies will keep innovating technologies and products to stay in the race.

In-Depth research report on OTT Devices and Services Market: